Statements (55)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:healthcare_organization
|
| gptkbp:affects |
serous cavities
|
| gptkbp:associated_with |
gptkb:HIV
gptkb:HHV-8 |
| gptkbp:can_lead_to |
weight loss
fever night sweats lymphadenopathy |
| gptkbp:first_described_by |
1990s
|
| https://www.w3.org/2000/01/rdf-schema#label |
primary effusion lymphoma
|
| gptkbp:is_associated_with |
gptkb:malignant_mesothelioma
other malignancies other lymphomas pleural effusion due to infection |
| gptkbp:is_characterized_by |
C D20 positivity
C D30 positivity EBV association effusions high proliferation index lack of C D23 lack of C D5 large atypical lymphoid cells pleural effusion without a mass |
| gptkbp:is_often_used_in |
men
older adults immunocompromised patients |
| gptkbp:is_part_of |
hematologic malignancies
HIV-associated malignancies |
| gptkbp:is_studied_in |
clinical trials
|
| gptkbp:occurs_in |
gptkb:multicentric_Castleman_disease
gptkb:healthcare_organization |
| gptkbp:recognizes |
flow cytometry
cytology PCR for HHV-8 |
| gptkbp:risk_factor |
organ transplantation
immunosuppression certain autoimmune diseases chronic inflammatory diseases |
| gptkbp:social_responsibility |
imaging studies
biopsy poor |
| gptkbp:symptoms |
ascites
pleural effusion pericardial effusion |
| gptkbp:treatment |
gptkb:bortezomib
gptkb:lenalidomide gptkb:rituximab gptkb:drug chemotherapy oncologists |
| gptkbp:type_of |
gptkb:healthcare_organization
|
| gptkbp:bfsParent |
gptkb:Human_Herpesvirus_8
gptkb:human_herpesvirus_8 gptkb:Kaposi's_sarcoma-associated_herpesvirus |
| gptkbp:bfsLayer |
4
|